The options market reveals how far a stock could move by expiration. Implied volatility surface analysis and expected move calculations to decode the market's true price expectations. Understand option market expectations with comprehensive IV analysis.
Candel Therapeutics Inc. (CADL) is a clinical-stage biotech company focused on developing novel immunotherapy treatments for oncology indications. As of April 18, 2026, CADL shares are trading at $6.37, representing a 23.45% gain in recent trading sessions, marking one of the more notable short-term price moves among small-cap biotech names this month. This analysis evaluates key technical levels, recent market context, and potential near-term price action scenarios for the stock, with no recent
How to Value Candel (CADL) Stock (Bullish Sentiment) 2026-04-18 - Block Trade Flow
CADL - Stock Analysis
4528 Comments
838 Likes
1
Falicity
Senior Contributor
2 hours ago
This would’ve been perfect a few hours ago.
👍 263
Reply
2
Markkevin
Trusted Reader
5 hours ago
I read this and now I feel strange.
👍 21
Reply
3
Radine
Daily Reader
1 day ago
Short-term traders are actively responding to news, creating volatility while long-term trends remain intact.
👍 76
Reply
4
Shavonn
Active Contributor
1 day ago
That deserves a meme. 😂
👍 296
Reply
5
Tanaeja
Community Member
2 days ago
This feels like a secret but no one told me.
👍 30
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.